When authorized generics are introduced to the market without any generic competition, does this help reduce payer cost and improve pharmacy margins?

Yes 11%

No 0%

Generally yes, but depends on pricing of AG and whether it’s reimbursed as a brand or generic 44%

Generally no, but payer rebates and pharmacy discounts may help 44%

Give others the chance to vote.